EOMES‐positive CD4+ T cells are increased in PTPN22 (1858T) risk allele carriers

Authors:

Abstract
The presence of the PTPN22 risk allele (1858T) is associated with several autoimmune diseases including rheumatoid arthritis (RA). Despite a number of studies exploring the function of PTPN22 in T cells, the exact impact of the PTPN22 risk allele on T‐cell function in humans is still unclear. In this study, using RNA sequencing, we show that, upon TCR‐activation, naïve human CD4+ T cells homozygous for the PTPN22 risk allele overexpress a set of genes including CFLAR and 4‐1BB, which are important for cytotoxic T‐cell differentiation. Moreover, the protein expression of the T‐box transcription factor Eomesodermin (EOMES) was increased in T cells from healthy donors homozygous for the PTPN22 risk allele and correlated with a decreased number of naïve CD4+ T cells. There was no difference in the frequency of other CD4+ T‐cell subsets (Th1, Th17, Tfh, Treg). Finally, an accumulation of EOMES+CD4+ T cells was observed in synovial fluid of RA patients with a more pronounced production of Perforin‐1 in PTPN22 risk allele carriers. Altogether, we propose a novel mechanism of action of PTPN22 risk allele through the generation of cytotoxic CD4+ T cells and identify EOMES+CD4+ T cells as a relevant T‐cell subset in RA pathogenesis.
Funding Information
  • Knut och Alice Wallenbergs Stiftelse
  • European Research Council (ERC grant number 260167)

This publication has 64 references indexed in Scilit: